Pinsent Masons advises UK Government on first purchase of Covid-19 antivirals
21 Oct 2021 | 02:18 pm |
Multinational law firm Pinsent Masons has advised the UK government on its contracts for the purchase of significant volumes of two novel, Covid-19 specific, antivirals.
The two antivirals have been developed by MSD and Pfizer. MSD’s antiviral - Molnupiravir - has been shown to cut hospitalisation rates of Covid-19 patients by nearly half. It is also the first oral treatment that has been effective in treating Covid-19. The treatment works by targeting an enzyme the virus uses to make copies of itself. The Pfizer antiviral is in late-stage clinical development.
Commenting on the deal, lead life sciences partner Allistair Booth said:
"The response of the life sciences sector to the Covid-19 pandemic and what the sector has achieved is nothing short of phenomenal. The development of these antivirals is a further example of that. These drugs could play a key role in reducing hospitalisation of Covid-19 patients in the UK, helping to alleviate pressure on the NHS. We are proud to have worked with the UK government on securing these agreements.”
Alongside Allistair, the team working on the deals included life sciences experts Mario Subramaniam, Niki Ruprai, Andrew Cornforth, Kiah York, Serena Hitchcock, Ioana Chiva and Jackie Harris.
This follows the team’s work advising the UK government on its initial procurement of the Pfizer BioNTech Covid-19 vaccine and for its autumn revaccination programme.
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons has advised Tokai Carbon on the sale of its German subsidiary TOKAI ERFTCARBON GmbH
Multinational law firm Pinsent Masons has advised Tokai Carbon Co., Ltd. (“Tokai Carbon”) on the sale of its German subsidiary TOKAI ERFTCARBON GmbH (“TEG”), to Lenbach Equity Opportunities III. GmbH & Co. KG, which is exclusively advised by DUBAG Investment Advisory GmbH (“DUBAG”).
Pinsent Masons advises on Shackleton exit
Multinational law firm Pinsent Masons has advised the shareholders of independent financial advisory and wealth management firm Shackleton, including the private equity buy-and-build specialist Sovereign Capital Partners, on the exit to Lee Equity Partners.
Pinsent Masons named by The Times as a Top 50 Employer for Gender Equality
Multinational law firm Pinsent Masons has been announced by Business in the Community as one of The Times Top 50 Employers for Gender Equality in 2025. This year’s list marks the sixth time that the firm has been recognised for its commitment to embedding gender equality into all levels of the organisation.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons has advised Tokai Carbon on the sale of its German subsidiary TOKAI ERFTCARBON GmbH
Multinational law firm Pinsent Masons has advised Tokai Carbon Co., Ltd. (“Tokai Carbon”) on the sale of its German subsidiary TOKAI ERFTCARBON GmbH (“TEG”), to Lenbach Equity Opportunities III. GmbH & Co. KG, which is exclusively advised by DUBAG Investment Advisory GmbH (“DUBAG”).
Pinsent Masons advises on Shackleton exit
Multinational law firm Pinsent Masons has advised the shareholders of independent financial advisory and wealth management firm Shackleton, including the private equity buy-and-build specialist Sovereign Capital Partners, on the exit to Lee Equity Partners.
Pinsent Masons advises Gulf Nav on its AED 3.2 billion reverse takeover of Brooge Petroleum Gas Investment from Brooge Energy Limited
Multinational law firm Pinsent Masons has advised Gulf Navigation Holding PJSC (Gulf Nav), the only maritime and shipping company listed on the Dubai Financial Market, on its landmark reverse takeover of Brooge Petroleum and Gas Investment Company from NASDAQ-listed Brooge Energy Limited.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]